Shares in California-based Dextera Surgical Inc. jumped 7.75%, ending Wednesday's trading session at $0.34. The stock recorded a trading volume of 21.18 million shares, which was higher than its three months average volume of 6.92 million shares. The Company's shares have surged 40.73% in the last one month and 82.43% over the last three months. The stock is trading 28.52% above its 50-day moving average. Moreover, shares of Dextera Surgical, which designs and manufactures proprietary stapling devices for minimally invasive surgical procedures in the US, Japan, Germany, and internationally, have a Relative Strength Index (RSI) of 68.31.
On August 16th, 2017, research firm Ladenburg Thalmann initiated a 'Buy' rating on the Company's stock, with a target price of $0.80 per share.
On August 21st, 2017, Dextera Surgical announced that Julian Nikolchev, President and CEO, will present a corporate update at the Southern California Investor Conference on August 24th, 2017, at 8:30 a.m. PT in Newport Beach, CA. The live and subsequently archived webcast of the presentation may be accessed under the Investor Relations section of the Company's website.
